The Company is developing its MultiStem cell therapy product, a patented, adult-derived "off-the-shelf" stem cell product platform for disease indications in the cardiovascular, neurological, inflammatory and immune disease areas.
http://ift.tt/1duPhSs
http://ift.tt/1duPhSs
No comments:
Post a Comment